iBio, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for IBIO, updated each market day.
IBIO AI Sentiment
AI sees no strong directional signal for iBio, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About iBio, Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Sector
Exchange
Market Cap
$75,995,834
Cap Tier
Employees
20
Headquarters
NEW YORK, NY
Listed Since
Aug. 19, 2008
Website
IBIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IBIO Volatility
iBio, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
